Prospective Study of Hyperglycemia and Cancer Risk

Table 1—

Baseline characteristics of participants in the Västerbotten Intervention Project, northern Sweden

	Women	Men
n	35,362	33,424
Age at entry (years) (distribution %)	46.1 ± 9.7	46.0 ± 9.8
29–35	13	14
36–45	32	32
46–55	31	31
56–61	24	23
Years of follow-up	8.3 ± 3.5	8.2 ± 3.6
Cancer cases (n)	1,440	1,251
Person-years at risk	292,652	273,715
BMI (kg/m²)*	25.3 ± 4.2	26.0 ± 3.5
Normal (18.5–25)	56	43
Overweight (25–30)	31	46
Obese (>30)	13	11
Smoking status
Current	21	18
Former	19	25
Never	60	57
Fasting glucose (n)	35,128	33,173
Fasting glucose (mmol/l)*	5.3 ± 0.9	5.5 ± 1.1
Normal (<6.1)	89	85
IFG (6.1–6.9)	9	12
Diabetic range (>6.9)	2	3
Cohort participants with OGTT† (n)	33,293	31,304
Postload glucose (mmol/l)	6.9 ± 1.6	6.3 ± 1.8
Normal (<8.9)	92	94
IGT ( 8.9–12.1)	7	5
Diabetic range (>12.1)	1	1

Data are means ± SD, percent, or n, unless otherwise indicated.
*
↵* Fasting glucose levels in venous plasma.
†
↵† Postload glucose levels in capillary plasma 2 h after an oral glucose tolerance test (OGTT) of 75 g glucose according to the World Health Organization (21).